Li-Fraumeni syndrome in adult patients with acute lymphoblastic leukemia

被引:0
|
作者
Zarubina, Kseniia, I [1 ]
Parovichnikova, Elena N. [1 ]
Surin, Vadim L. [1 ]
Pshenichnikova, Olesia S. [1 ]
Gavrilina, Olga A. [1 ]
Isinova, Galina A. [1 ]
Troitskaya, Vera V. [1 ]
Sokolov, Andrei N. [1 ]
Galtseva, Irina, V [1 ]
Kapranov, Nikolai M. [1 ]
Davydova, Juliia O. [1 ]
Obukhova, Tatiana N. [1 ]
Nikulina, Elena E. [1 ]
Sudarikov, Andrei B. [1 ]
Savchenko, Valerii G. [1 ]
机构
[1] Natl Res Ctr Hematol, Moscow, Russia
关键词
acute lymphoblastic leukemia; hereditary predisposition; Li-Fraumeni syndrome; TP53; mutations; CANCER-RISK; HEMATOLOGIC MALIGNANCIES; BREAST-CANCER; MUTATIONS; PREDISPOSITION; CHILDREN; MOTHERS;
D O I
10.26442/00403660.2021.07.200913
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Li-Fraumeni syndrome (LFS) is a rare, autosomal dominant, hereditary disorder that is characterized by an increased risk for certain types of cancer, acute lymphoblastic leukemia (ALL), particularly. Germline TP53 mutations are associated with LFS. Genetic counseling and follow-up is essential for patients with LFS and their relatives. Special therapeutic approaches are needed for treatment of oncological disease in these patients. The article presents a series of clinical cases of patients with ALL and SLF, considers general issues of diagnosis and treatment of adult patients with this hereditary genetic syndrome. Aim. Describe clinical observations of patients with acute lymphoblastic leukemia (ALL) and LFS and consider general issues of diagnosis and treatment of adult patients with LFS and ALL. Materials and methods. TP53 gene mutations were screened using Sanger sequencing in 180 de novo patients with Ph-negative (B- and T-cell) and Ph-positive ALL treated by Russian multicenter protocols (ALL-2009, ALL-2012, ALL-2016) at the National Research Center for Hematology, Moscow, Russia, and at the hematology departments of regional clinics of Russia (multicenter study participants). Results. TP53 gene mutations were found in 7.8% (n=14) of de novo ALL patients. In patients, whose biological material was available TP53 gene mutational status was determined in non-tumor cells (bone marrow and peripheral blood during remission, bone marrow samples after allogeneic hematopoietic stem cells transplantation and in tissue of non-hematopoietic origin) for discriminating germline mutations. The analysis included 5 patients (out of 14 with TP53 mutations), whose non-tumor biological material was available for research. Germline status was confirmed in 4 out of 5 - B-cell ALL (n=3), T-cell ALL (n=1) - investigated patients. Conclusion. Practical value of the research is the observation that the greater part of TP53 gene mutations in patients with Ph-negative B-cell ALL are germinal and associated with LFS.
引用
收藏
页码:763 / 769
页数:7
相关论文
共 50 条
  • [1] Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndrome
    Winter, Greta
    Kirschner-Schwabe, Renate
    Groeneveld-Krentz, Stefanie
    Escherich, Gabriele
    Moericke, Anja
    von Stackelberg, Arend
    Stanulla, Martin
    Bailey, Simon
    Richter, Lisa
    Steinemann, Doris
    Ripperger, Tim
    Escudero, Adela
    Farah, Roula
    Lohi, Olli
    Wadt, Karin
    Jongmans, Marjolijn
    van Engelen, Nienke
    Eckert, Cornelia
    Kratz, Christian Peter
    LEUKEMIA, 2021, 35 (05) : 1475 - 1479
  • [2] Li-Fraumeni Syndrome and its Association With Acute Leukemia
    Mattox, Sharon N. P.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S324 - S325
  • [3] Treatment and Response Evaluation Challenges in a Pregnant Woman With B-Cell Lymphoblastic Leukemia and Li-Fraumeni Syndrome
    Erikstein, Bjarte Skoe
    Ahmed, Aymen Bushra
    Forthun, Rakel Brendsdal
    Leh, Friedemann
    Gjertsen, Bjorn Tore
    Reikvam, Hakon
    JOURNAL OF HEMATOLOGY, 2023, 12 (02) : 92 - 99
  • [4] Cumulative risk of skin cancer in patients with Li-Fraumeni syndrome
    Nieuwenburg, S. A.
    Adan, F.
    Ruijs, M. W. G.
    Sonke, G. S.
    van Leerdam, M. E.
    Crijns, M. B.
    FAMILIAL CANCER, 2020, 19 (04) : 347 - 351
  • [5] The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome
    Ross, Jessica
    Bojadzieva, Jasmina
    Peterson, Susan
    Noblin, Sarah Jane
    Yzquierdo, Rebecca
    Askins, Martha
    Strong, Louise
    GENETICS IN MEDICINE, 2017, 19 (09) : 1064 - 1070
  • [6] Li-Fraumeni syndrome
    Andres Ossa, Carlos
    Molina, Gustavo
    Maria Cock-Rada, Alicia
    BIOMEDICA, 2016, 36 (02): : 182 - 187
  • [7] Prenatal diagnosis in Li-Fraumeni syndrome
    Avigad, S
    Peleg, D
    Barel, D
    Benyaminy, H
    Ben-Baruch, N
    Taub, E
    Shohat, M
    Goshen, Y
    Cohen, IJ
    Yaniv, I
    Zaizov, R
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (09) : 541 - 545
  • [8] Melanoma in patients with Li-Fraumeni syndrome (Review)
    Sandru, Florica
    Dumitrascu, Mihai Cristian
    Petca, Aida
    Carsote, Mara
    Petca, Razvan-Cosmin
    Ghemigian, Adina
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (01)
  • [9] LI-FRAUMENI SYNDROME IN A TURKISH FAMILY
    Karakas, Zeynep
    Tugcu, Deniz
    Unuvar, Aysegul
    Atay, Didem
    Akcay, Arzu
    Gedik, Hakan
    Kayserili, Hulya
    Dogan, Oner
    Anak, Sema
    Devecioglu, Omer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (04) : 297 - 305
  • [10] The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome
    Yoshida, Tsukasa
    Tajika, Masahiro
    Tanaka, Tsutomu
    Ishihara, Makoto
    Hirayama, Yutaka
    Mizuno, Nobumasa
    Hara, Kazuo
    Hijioka, Susumu
    Imaoka, Hiroshi
    Hieda, Nobuhiro
    Okuno, Nozomi
    Kinoshita, Takashi
    Bhatia, Vikram
    Shimizu, Yasuhiro
    Yatabe, Yasushi
    Yamao, Kenji
    Niwa, Yasumasa
    INTERNAL MEDICINE, 2017, 56 (03) : 295 - 300